New Drug Applications Archive - April 2012
Get news by email or subscribe to our news feeds.
April 2, 2012
- Raptor Pharmaceutical Corp. Submits New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis
- Tekmira Provides Update on Licensed Product Candidate, Marqibo
April 3, 2012
April 4, 2012
April 5, 2012
- Sanofi and Regeneron Announce Regulatory and Clinical Update for Zaltrap (aflibercept)
- FDA Advisory Committee Recommends Approval of Mirabegron - Investigational Overactive Bladder Treatment from Astellas
April 10, 2012
April 12, 2012
April 18, 2012
- Depomed Announces Intent to File NDA for Serada for Treatment of Menopausal Hot Flashes
- Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
April 26, 2012
April 27, 2012
- The International Myeloma Foundation Says Pomalidomide, an Important New Drug for Patients, Has Been Submitted for FDA Approval
- Takeda Receives Complete Response Letter from the FDA for Type 2 Diabetes Investigational Therapies Alogliptin and Fixed-Dose Combination Alogliptin and Pioglitazone
- Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
- Dynavax Reports Heplisav BLA Submission
